Diamond Biotechnology Co

Diamond Biotechnology Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Diamond Biotechnology Co (6815.TWO) as of Oct 31, 2026 is -785.00. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 673.72 — a change of -216.52% (lower).

EV/FCF

-785.00

YoY

-216.52%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Diamond Biotechnology Co is 2025 -785.00 . EV/FCF (Enterprise Value to Free Cash Flow) of Diamond Biotechnology Co was 2024 673.72 . It decreases by -216.52% lower compared to the previous year.

The Diamond Biotechnology Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
140.97 TWD
Jan 1, 2019
366.13 TWD
Jan 1, 2020
172.10 TWD
Jan 1, 2021
-129.00 TWD
Jan 1, 2022
29.22 TWD
Jan 1, 2023
-16.88 TWD
Jan 1, 2024
673.72 TWD
Jan 1, 2025
-785.00 TWD
The Diamond Biotechnology Co EV/FCF history
YEAREV/FCFYoY
-785.00-216.52%
673.72-4,090.96%
-16.88-157.78%
29.22-122.65%
-129.00-174.96%
172.10-53.00%
366.13+159.72%
140.97-479.49%
-37.15—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diamond Biotechnology Co Stock analysis

What does Diamond Biotechnology Co do? Diamond Biotechnology Co., Ltd. generates revenue through the research, development, manufacturing, and sale of skincare products and medical equipment. The company's skincare products include facial masks, lotions, creams, and essences, primarily used for facial skin care and cleaning. Medical equipment offerings consist of wires, sonic wave devices, radio wave devices, frozen fat reduction equipment, and micro plastic surgery consumables such as botulinum and collagen injections, targeting skin wrinkle and sagging improvement. The firm also provides medical equipment leasing services and medical beauty management consulting services to its clients. The primary customers for skincare products are individuals seeking facial care solutions, while medical equipment and consumables are purchased by clinics and medical facilities specializing in aesthetic procedures. The company serves both domestic and overseas markets, with its medical beauty management consulting services catering to businesses in the aesthetic industry. Diamond Biotechnology focuses on direct sales of its products and services, leveraging its domestic market presence and expanding into international territories to drive revenue growth. Revenue streams are diversified across product categories and service offerings, with skincare products accounting for a significant portion of sales alongside medical equipment and consumables. The company's medical equipment leasing services provide recurring income, while consulting services support long-term client relationships. By maintaining a dual focus on consumer skincare and professional medical aesthetics, Diamond Biotechnology ensures steady demand across its product lines and service segments. Diamond Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diamond Biotechnology Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Diamond Biotechnology Co is -785.00 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Diamond Biotechnology Co changed from 673.72 to -785.00, representing a -216.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Diamond Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Diamond Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Diamond Biotechnology Co

All Key Metrics — Diamond Biotechnology Co